Ondansetron
Product Images NDC 50436-0390

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 50436-0390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl504360390)

Ondansetron orally disintegrating tablets, 4 mg strength, packaged in a carton containing 30 tablets (3 blister cards each with 10 tablets). Distributed by Aurobindo Pharma USA, Inc., East Windsor, NJ. Label includes NDC 50436-0390-1 and storage instructions to keep at 20-25°C controlled room temperature. The label specifies the product is RX only and includes lot, expiration, and manufacturing details placeholders.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure of Ondansetron, depicting its molecular framework including a fused indole ring system and a substituted imidazole group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.